Circulation, ISSN 0009-7322, 04/2013, Volume 127, Issue 16, pp. 1647 - 1655
Background-There is a paucity of long-term data comparing biological versus mechanical aortic valve prostheses in older individuals. Methods and Results-We...
heart valve prosthesis | aortic valve | comparative effectiveness research | PROPENSITY-SCORE | REPLACEMENT | CARDIAC & CARDIOVASCULAR SYSTEMS | HEART-VALVE | PERIPHERAL VASCULAR DISEASE | OUTCOMES | BIOPROSTHETIC VALVE | United States - epidemiology | Bioprosthesis - statistics & numerical data | Prognosis | Age Factors | Humans | Medicare - statistics & numerical data | Male | Risk | Aortic Valve - surgery | Postoperative Complications - mortality | Societies, Medical | Reoperation - statistics & numerical data | Aged, 80 and over | Female | Stroke - epidemiology | Retrospective Studies | Cardiology | Databases, Factual | Hemorrhage - epidemiology | Comorbidity | Heart Valve Prosthesis - adverse effects | Bioprosthesis - adverse effects | Treatment Outcome | Postoperative Complications - epidemiology | Endocarditis - epidemiology | Thoracic Surgery | Heart Valve Prosthesis - statistics & numerical data | Aged | Aged patients | Care and treatment | Usage | Safety and security measures | Cardiovascular instruments, Implanted | Patient outcomes
heart valve prosthesis | aortic valve | comparative effectiveness research | PROPENSITY-SCORE | REPLACEMENT | CARDIAC & CARDIOVASCULAR SYSTEMS | HEART-VALVE | PERIPHERAL VASCULAR DISEASE | OUTCOMES | BIOPROSTHETIC VALVE | United States - epidemiology | Bioprosthesis - statistics & numerical data | Prognosis | Age Factors | Humans | Medicare - statistics & numerical data | Male | Risk | Aortic Valve - surgery | Postoperative Complications - mortality | Societies, Medical | Reoperation - statistics & numerical data | Aged, 80 and over | Female | Stroke - epidemiology | Retrospective Studies | Cardiology | Databases, Factual | Hemorrhage - epidemiology | Comorbidity | Heart Valve Prosthesis - adverse effects | Bioprosthesis - adverse effects | Treatment Outcome | Postoperative Complications - epidemiology | Endocarditis - epidemiology | Thoracic Surgery | Heart Valve Prosthesis - statistics & numerical data | Aged | Aged patients | Care and treatment | Usage | Safety and security measures | Cardiovascular instruments, Implanted | Patient outcomes
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 09/2012, Volume 60, Issue 11, pp. 971 - 977
Objectives: The aim of this study was to evaluate the risks and benefits of short-term anticoagulation in patients receiving aortic valve bioprostheses....
aortic valve replacement | outcomes | anticoagulation strategies | REPLACEMENT | TRIAL | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | COMPARING WARFARIN | ANTITHROMBOTIC THERAPY | ASPIRIN | Humans | Risk Factors | Heart Valve Prosthesis - adverse effects | Bioprosthesis - adverse effects | Warfarin - adverse effects | Anticoagulants - therapeutic use | Male | Treatment Outcome | Aortic Valve - surgery | Thoracic Surgery | Thromboembolism - epidemiology | Anticoagulants - adverse effects | Incidence | Warfarin - therapeutic use | Drug Therapy, Combination - adverse effects | Thromboembolism - prevention & control | Aspirin - adverse effects | Survival Analysis | Aged, 80 and over | Female | Aged | Aspirin - therapeutic use | Hemorrhage - chemically induced | Cohort Studies
aortic valve replacement | outcomes | anticoagulation strategies | REPLACEMENT | TRIAL | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | COMPARING WARFARIN | ANTITHROMBOTIC THERAPY | ASPIRIN | Humans | Risk Factors | Heart Valve Prosthesis - adverse effects | Bioprosthesis - adverse effects | Warfarin - adverse effects | Anticoagulants - therapeutic use | Male | Treatment Outcome | Aortic Valve - surgery | Thoracic Surgery | Thromboembolism - epidemiology | Anticoagulants - adverse effects | Incidence | Warfarin - therapeutic use | Drug Therapy, Combination - adverse effects | Thromboembolism - prevention & control | Aspirin - adverse effects | Survival Analysis | Aged, 80 and over | Female | Aged | Aspirin - therapeutic use | Hemorrhage - chemically induced | Cohort Studies
Journal Article
Astrophysical Journal, ISSN 0004-637X, 03/2019, Volume 873, Issue 2, p. 111
We describe here the most ambitious survey currently planned in the optical, the Large Synoptic Survey Telescope (LSST). The LSST design is driven by four main...
methods: observational | stars: general | IA SUPERNOVAE | surveys | DARK-ENERGY CONSTRAINTS | MILKY-WAY TOMOGRAPHY | GAMMA-RAY BURSTS | TIDAL DISRUPTION EVENTS | Galaxy: general | DIGITAL SKY SURVEY | ASTRONOMY & ASTROPHYSICS | PROPER MOTION STARS | cosmology: observations | SAGITTARIUS DWARF GALAXY | astrometry | SIZE DISTRIBUTION | LENSING POWER SPECTRUM | ASTRONOMY AND ASTROPHYSICS | stars | galaxy | cosmology observations | Fysik | Physical Sciences | Naturvetenskap | Natural Sciences
methods: observational | stars: general | IA SUPERNOVAE | surveys | DARK-ENERGY CONSTRAINTS | MILKY-WAY TOMOGRAPHY | GAMMA-RAY BURSTS | TIDAL DISRUPTION EVENTS | Galaxy: general | DIGITAL SKY SURVEY | ASTRONOMY & ASTROPHYSICS | PROPER MOTION STARS | cosmology: observations | SAGITTARIUS DWARF GALAXY | astrometry | SIZE DISTRIBUTION | LENSING POWER SPECTRUM | ASTRONOMY AND ASTROPHYSICS | stars | galaxy | cosmology observations | Fysik | Physical Sciences | Naturvetenskap | Natural Sciences
Journal Article
4.
Full Text
The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data
Brain imaging and behavior, ISSN 1931-7557, 2014, Volume 8, Issue 2, pp. 153 - 182
The Enhancing NeuroImaging Genetics through Meta-Analysis (ENIGMA) Consortium is a collaborative network of researchers working together on a range of...
Neurosciences | Biomedicine | GWAS | MRI | Multi-site | Consortium | Genetics | Neuropsychology | Psychiatry | Neuroradiology | Meta-analysis | COMMON VARIANTS | ALZHEIMERS-DISEASE | HIPPOCAMPAL ATROPHY | NEUROIMAGING | APOLIPOPROTEIN-E | QUANTITATIVE TRAIT LOCI | HUMAN BRAIN STRUCTURE | CORTICAL SURFACE-AREA | MULTIVARIATE PARALLEL ICA | WHITE-MATTER MICROSTRUCTURE | GENOME-WIDE ASSOCIATION | Neuroimaging - methods | Cooperative Behavior | Meta-Analysis as Topic | Brain Mapping - methods | Genome-Wide Association Study - methods | Humans | Medicine | Consortia | Neuroimaging | Usage | Conferences, meetings and seminars | Analysis | Life Sciences | Neurons and Cognition | Genetic Neuroimaging in Aging and Age-Related Diseases | Basic Medicine | Social Sciences | Medical and Health Sciences | Medicin och hälsovetenskap | Psychology | Samhällsvetenskap | Medicinska och farmaceutiska grundvetenskaper | Psykologi | Neurovetenskaper
Neurosciences | Biomedicine | GWAS | MRI | Multi-site | Consortium | Genetics | Neuropsychology | Psychiatry | Neuroradiology | Meta-analysis | COMMON VARIANTS | ALZHEIMERS-DISEASE | HIPPOCAMPAL ATROPHY | NEUROIMAGING | APOLIPOPROTEIN-E | QUANTITATIVE TRAIT LOCI | HUMAN BRAIN STRUCTURE | CORTICAL SURFACE-AREA | MULTIVARIATE PARALLEL ICA | WHITE-MATTER MICROSTRUCTURE | GENOME-WIDE ASSOCIATION | Neuroimaging - methods | Cooperative Behavior | Meta-Analysis as Topic | Brain Mapping - methods | Genome-Wide Association Study - methods | Humans | Medicine | Consortia | Neuroimaging | Usage | Conferences, meetings and seminars | Analysis | Life Sciences | Neurons and Cognition | Genetic Neuroimaging in Aging and Age-Related Diseases | Basic Medicine | Social Sciences | Medical and Health Sciences | Medicin och hälsovetenskap | Psychology | Samhällsvetenskap | Medicinska och farmaceutiska grundvetenskaper | Psykologi | Neurovetenskaper
Journal Article
Circulation, ISSN 0009-7322, 04/2013, Volume 127, Issue 13, pp. 1395 - 1403
Background-Black, Hispanic, and Asian patients have been underrepresented in percutaneous coronary intervention clinical trials; therefore, there are limited...
Percutaneous coronary intervention | Coronary artery disease | Outcome assessment | Continental population groups | Drug-eluting stents | Ethnic groups | coronary artery disease | SURVIVAL | REVASCULARIZATION | CARDIAC & CARDIOVASCULAR SYSTEMS | drug-eluting stents | RACIAL-DIFFERENCES | VETERANS | RISK | continental population groups | percutaneous coronary intervention | HEART-DISEASE | DYNAMIC REGISTRY | ethnic groups | PERIPHERAL VASCULAR DISEASE | outcome assessment | ARTERY-DISEASE | Drug-Eluting Stents - trends | Cardiovascular Diseases - ethnology | Follow-Up Studies | United States - ethnology | Ethnic Groups - ethnology | Continental Population Groups - ethnology | Humans | Cardiovascular Diseases - therapy | Male | Treatment Outcome | Medicare - trends | Drug-Eluting Stents - adverse effects | Medicaid - trends | Aged, 80 and over | Female | Registries | Aged | Databases, Factual - trends | Stents - trends | Stents - adverse effects | Longitudinal Studies | Cardiovascular Diseases - diagnosis | Cohort Studies | Treatment outcome | Care and treatment | Usage | Demographic aspects | Patient outcomes | Research | Cardiovascular diseases | Health aspects
Percutaneous coronary intervention | Coronary artery disease | Outcome assessment | Continental population groups | Drug-eluting stents | Ethnic groups | coronary artery disease | SURVIVAL | REVASCULARIZATION | CARDIAC & CARDIOVASCULAR SYSTEMS | drug-eluting stents | RACIAL-DIFFERENCES | VETERANS | RISK | continental population groups | percutaneous coronary intervention | HEART-DISEASE | DYNAMIC REGISTRY | ethnic groups | PERIPHERAL VASCULAR DISEASE | outcome assessment | ARTERY-DISEASE | Drug-Eluting Stents - trends | Cardiovascular Diseases - ethnology | Follow-Up Studies | United States - ethnology | Ethnic Groups - ethnology | Continental Population Groups - ethnology | Humans | Cardiovascular Diseases - therapy | Male | Treatment Outcome | Medicare - trends | Drug-Eluting Stents - adverse effects | Medicaid - trends | Aged, 80 and over | Female | Registries | Aged | Databases, Factual - trends | Stents - trends | Stents - adverse effects | Longitudinal Studies | Cardiovascular Diseases - diagnosis | Cohort Studies | Treatment outcome | Care and treatment | Usage | Demographic aspects | Patient outcomes | Research | Cardiovascular diseases | Health aspects
Journal Article
Ophthalmology, ISSN 0161-6420, 07/2018, Volume 125, Issue 7, pp. 1054 - 1063
To assess systemic vascular endothelial growth factor (VEGF)-A levels after treatment with intravitreous aflibercept, bevacizumab, or ranibizumab....
METAANALYSIS | PHARMACOKINETICS | BEVACIZUMAB | INJECTION | OPHTHALMOLOGY | RETINOPATHY | SERUM | RANIBIZUMAB | PREMATURITY | DEGENERATION
METAANALYSIS | PHARMACOKINETICS | BEVACIZUMAB | INJECTION | OPHTHALMOLOGY | RETINOPATHY | SERUM | RANIBIZUMAB | PREMATURITY | DEGENERATION
Journal Article